MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

Nearly two years after Takeda pulled its US marketing application for a vaccine against dengue fever, MSD has advanced a rival shot into phase 3. The international MOBILIZE-1 trial is looking at a ...

Here is the latest in the rider line-up for the 2026 MotoGP season - plus the latest rumours about what might be next... Ducati’s “dream team” factory Lenovo line-up of Francesco Bagnaia and Marc ...